Literature DB >> 29689302

Cyclodextrins as excipients in tablet formulations.

Jaime Conceição1, Oluwatomide Adeoye2, Helena Maria Cabral-Marques3, José Manuel Sousa Lobo4.   

Abstract

This paper aims to provide a critical review of cyclodextrins as excipients in tablet formulations, highlighting: (i) the principal pharmaceutical applications of cyclodextrins; (ii) the most relevant technological aspects in pharmaceutical formulation development; and (iii) the actual regulatory status of cyclodextrins. Moreover, several illustrative examples are presented. Cyclodextrins can be used as complexing excipients in tablet formulations for low-dose drugs. By contrast, for medium-dose drugs and/or when the complexation efficiency is low, the methods to enhance the complexation efficiency play a key part in reducing the cyclodextrin quantity. In addition, these compounds are used as fillers, disintegrants, binders and multifunctional direct compression excipients of the tablets.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29689302     DOI: 10.1016/j.drudis.2018.04.009

Source DB:  PubMed          Journal:  Drug Discov Today        ISSN: 1359-6446            Impact factor:   7.851


  14 in total

Review 1.  Insights into the release mechanisms of antioxidants from nanoemulsion droplets.

Authors:  Jordy Kim Ung Ling; Yen San Chan; Jobrun Nandong
Journal:  J Food Sci Technol       Date:  2021-05-09       Impact factor: 3.117

2.  Interaction of Commonly Used Oral Molecular Excipients with P-glycoprotein.

Authors:  Ruchika Bajaj; Lisa B Chong; Ling Zou; Eleftheria Tsakalozou; Zhanglin Ni; Kathleen M Giacomini; Deanna L Kroetz
Journal:  AAPS J       Date:  2021-09-15       Impact factor: 3.603

Review 3.  Cyclodextrin⁻Drug Inclusion Complexes: In Vivo and In Vitro Approaches.

Authors:  Simone Braga Carneiro; Fernanda Ílary Costa Duarte; Luana Heimfarth; Jullyana de Souza Siqueira Quintans; Lucindo José Quintans-Júnior; Valdir Florêncio da Veiga Júnior; Ádley Antonini Neves de Lima
Journal:  Int J Mol Sci       Date:  2019-02-02       Impact factor: 5.923

4.  Tablets of "Hydrochlorothiazide in Cyclodextrin in Nanoclay": A New Nanohybrid System with Enhanced Dissolution Properties.

Authors:  Francesca Maestrelli; Marzia Cirri; Fátima García-Villén; Ana Borrego-Sánchez; César Viseras Iborra; Paola Mura
Journal:  Pharmaceutics       Date:  2020-01-28       Impact factor: 6.321

Review 5.  The Role of Functional Excipients in Solid Oral Dosage Forms to Overcome Poor Drug Dissolution and Bioavailability.

Authors:  Jannes van der Merwe; Jan Steenekamp; Dewald Steyn; Josias Hamman
Journal:  Pharmaceutics       Date:  2020-04-25       Impact factor: 6.321

6.  Buccal Resveratrol Delivery System as a Potential New Concept for the Periodontitis Treatment.

Authors:  Magdalena Paczkowska-Walendowska; Jakub Dvořák; Natalia Rosiak; Ewa Tykarska; Emilia Szymańska; Katarzyna Winnicka; Marek A Ruchała; Judyta Cielecka-Piontek
Journal:  Pharmaceutics       Date:  2021-03-20       Impact factor: 6.321

7.  Combinations of Freeze-Dried Amorphous Vardenafil Hydrochloride with Saccharides as a Way to Enhance Dissolution Rate and Permeability.

Authors:  Gabriela Wiergowska; Dominika Ludowicz; Kamil Wdowiak; Andrzej Miklaszewski; Kornelia Lewandowska; Judyta Cielecka-Piontek
Journal:  Pharmaceuticals (Basel)       Date:  2021-05-11

Review 8.  Antiviral Drug Delivery System for Enhanced Bioactivity, Better Metabolism and Pharmacokinetic Characteristics.

Authors:  Ran Chen; Tingting Wang; Jie Song; Daojun Pu; Dan He; Jianjun Li; Jie Yang; Kailing Li; Cailing Zhong; Jingqing Zhang
Journal:  Int J Nanomedicine       Date:  2021-07-22

Review 9.  The Role of Cyclodextrins in the Design and Development of Triterpene-Based Therapeutic Agents.

Authors:  Alexandra Prodea; Alexandra Mioc; Christian Banciu; Cristina Trandafirescu; Andreea Milan; Roxana Racoviceanu; Roxana Ghiulai; Marius Mioc; Codruta Soica
Journal:  Int J Mol Sci       Date:  2022-01-10       Impact factor: 5.923

10.  Solubility enhancement of mefenamic acid by inclusion complex with β-cyclodextrin: in silico modelling, formulation, characterisation, and in vitro studies.

Authors:  Dounia Sid; Milad Baitiche; Zineb Elbahri; Ferhat Djerboua; Mokhtar Boutahala; Zouhair Bouaziz; Marc Le Borgne
Journal:  J Enzyme Inhib Med Chem       Date:  2021-12       Impact factor: 5.051

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.